Thoracic aortic aneurysm future or investigational therapies
|
Thoracic aortic aneurysm Microchapters |
|
Differentiating Thoracic Aortic Aneurysm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Thoracic aortic aneurysm future or investigational therapies On the Web |
|
FDA on Thoracic aortic aneurysm future or investigational therapies |
|
CDC on Thoracic aortic aneurysm future or investigational therapies |
|
Thoracic aortic aneurysm future or investigational therapies in the news |
|
Blogs on Thoracic aortic aneurysm future or investigational therapies |
|
Directions to Hospitals Treating Thoracic aortic aneurysm future or investigational therapies |
|
Risk calculators and risk factors for Thoracic aortic aneurysm future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or investigational therapies
Recent advances in thoracic aortic aneurysm treatment:
- The use of endovascular stent grafting, which is a less invasive alternative to open surgery, for the treatment of descending thoracic and thoracoabdominal aneurysms.
- Open-surgical versus endovascular stenting showed a decrease of operative mortality and a decrease in the occurrence of paraplegia, blood loss, length of ICU stay, and operative time with endovascular stenting.
- Even though late survival rates are equivalent between open surgical repair and endovascular repair, the early operative mortality rates of endovascular repair are lower
- The advances in aortic substitutes, cerebral protection, and perioperative care have led to improved results